Showing results (191-200 of 253) with videos related to
Sort By:
Pageof 26
European Journal of Endocrinology|January 6, 2011
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetesLian Engelen, Søren S Lund, Isabel Ferreira, et al.Diabetes Care|May 25, 2019
Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 DiabetesSigne A Winther, Jens C Øllgaard, Nete Tofte, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2016
Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 studyMorten Lindhardt, Frederik Persson, Petra Zürbig, et al.The Lancet. Diabetes & Endocrinology|February 10, 2015
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trialDick de Zeeuw, Deborah A Anzalone, Valerie A Cain, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKDAkshay S Desai, Robert Toto, Petr Jarolim, et al.Plos One|September 13, 2011
Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetesMaija Wessman, Carol Forsblom, Mari A Kaunisto, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 16, 2012
Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)Hans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.Journal of the American Society of Nephrology : JASN|September 23, 2021
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR TrialHiddo J L Heerspink, Di Xie, George Bakris, et al.Plos One|March 17, 2023
Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuriaChristina Gjerlev Poulsen, Daniel G K Rasmussen, Federica Genovese, et al.Current Medical Research and Opinion|November 2, 2006
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertensionAndrew J Palmer, William J Valentine, Daniel M D Tucker, et al.Pageof 26